PA
Perceptive Advisors LLC cut its NAUT stake below 5%
Perceptive Advisors LLC reported owning 3.9% of Nautilus Biotechnology, Inc. (NAUT) (4,944,512 shares) in a Schedule 13D filed Nov 3, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 3, 2026
- Source
- Schedule 13D